BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+27.77%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$8.73B
AUM Growth
+$8.73B
(+21%)
Cap. Flow
+$239M
Cap. Flow
% of AUM
2.73%
Top 10 Holdings %
Top 10 Hldgs %
31.85%
Holding
234
New
17
Increased
81
Reduced
66
Closed
12
Top Buys
| 1 |
Biogen
BIIB
|
$136M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$65.8M |
| 3 |
Mersana Therapeutics
MRSN
|
$51.3M |
| 4 |
Arvinas
ARVN
|
$46.7M |
| 5 |
AbbVie
ABBV
|
$36.3M |
Top Sells
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$154M |
| 2 |
Halozyme
HALO
|
$60.8M |
| 3 |
Pacific Biosciences
PACB
|
$57.2M |
| 4 |
CareDx
CDNA
|
$55.9M |
| 5 |
Charles River Laboratories
CRL
|
$52M |
Sector Composition
| 1 | Healthcare | 95.9% |
| 2 | Technology | 0.6% |
| 3 | Industrials | 0.33% |
| 4 | Financials | 0.11% |
| 5 | Consumer Discretionary | 0.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HMSY
226
DELISTED
HMS Holdings Corp.
HMSY
| – | – |
-916,984
| Closed | -$22M |
|
|
VAR
227
DELISTED
Varian Medical Systems, Inc.
VAR
| – | – |
-4,100
| Closed | -$705K |
|
|
NUVA
228
DELISTED
NuVasive, Inc.
NUVA
| – | – |
-82,100
| Closed | -$3.99M |
|
|
GTHX
229
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| – | – |
-721,925
| Closed | -$8.34M |
|
230
Sanofi
SNY
$122B
| – | – |
-57,000
| Closed | -$2.86M |
|
231
Sangamo Therapeutics
SGMO
$161M
| – | – |
-3,850,000
| Closed | -$36.4M |
|
232
Integra LifeSciences
IART
$1.18B
| – | – |
-122,426
| Closed | -$5.78M |
|
233
Huazhu Hotels Group
HTHT
$11.2B
| – | – |
-13,500
| Closed | -$584K |
|
234
Adobe
ADBE
$148B
| – | – |
-1,100
| Closed | -$539K |
|